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Abstract
Background: Publicly available genomic and transcriptomic data in searchable databases allow researchers to investigate
specific medical issues in thousands of patients. Many studies have highlighted the role lipids play in cancer initiation and
progression and reported nutritional interventions aimed at improving prognosis and survival. Therefore, there is an increasing
interest in the role that fat intake may play in cancer. It is known that there is a relationship between BMI and survival in patients
with cancer, and that there is an association between a high-fat diet and increased cancer risk. In some cancers, such as colorectal
cancer, obesity and high fat intake are known to increase the risk of cancer initiation and progression. On the contrary, in patients
undergoing treatment for melanoma, a higher BMI unexpectedly acts as a protective factor rather than a risk factor; this phenomenon
is known as the obesity paradox.
Objective: We aimed to identify the molecular mechanism underlying the obesity paradox, with the expectation that this could
indicate new effective strategies to reduce risk factors and improve protective approaches.
Methods: In order to determine the genes potentially involved in this process, we investigated the expression values of lipid-related
genes in patients with melanoma or colorectal cancer. We used available data from 2990 patients from 3 public databases (IST
[In Silico Transcriptomics] Online, GEO [Gene Expression Omnibus], and Oncomine) in an analysis that involved 3 consecutive
validation steps. Of this group, data from 1410 individuals were analyzed in the IST Online database (208 patients with melanoma
and 147 healthy controls, as well as 991 patients with colorectal cancer and 64 healthy controls). In addition, 45 melanoma, 18
nevi, and 7 healthy skin biopsies were analyzed in another database, GEO, to validate the IST Online data. Finally, using the
Oncomine database, 318 patients with melanoma (312 controls) and 435 patients with colorectal cancer (445 controls) were
analyzed.
Results: In the first and second database investigated (IST Online and GEO, respectively), patients with melanoma consistently
showed significantly (P<.001) lower expression levels of 4 genes compared to healthy controls: CD36, MARCO, FABP4, and
FABP7. This strong reduction was not observed in patients with colorectal cancer. An additional analysis was carried out on a
DNA-TCGA data set from the Oncomine database, further validating CD36 and FABP4.
Conclusions: The observed lower expression of genes such as CD36 and FABP4 in melanoma may reduce the cellular
internalization of fat and therefore make patients with melanoma less sensitive to a high dietary fat intake, explaining in part the
obesity paradox observed in patients with melanoma.
(JMIR Cancer 2020;6(1):e16974) doi: 10.2196/16974
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Genomic, transcriptomic, and proteomic data from several
thousand patients and corresponding healthy controls are now
publicly available on the internet, for many different pathologies,
including different types of cancers. This allows researchers to
investigate specific questions and medical hypotheses in silico,
directly in the human context, without certain ethical concerns.
We previously investigated expression data from several
thousand patients, and identified novel potential markers useful
for improving the diagnosis of melanoma and other solid cancers
[1,2], as well as novel therapeutic approaches that were then
validated in vitro by classical bench science [3,4]. In this study
we aimed to determine the molecular mechanisms underlying
the unexpected protective role of high fat intake in melanoma,
given that obesity is a known risk factor in other cancers. The
role fat plays in health maintenance as well as disease initiation
and progression is being extensively investigated. There is
particular interest in the protective role diet may have on cancer,
since different cancer types are associated with being overweight
or obese; furthermore, increased cancer mortality has been
linked to dyslipidemia [5]. In patients with cancer, metabolic
alterations impacting carbohydrate and lipid metabolism can
activate phosphoinositide 3-kinase (PI3K) pathway–dependent
oncogenic signaling, leading to an inflammatory state with
increased expression of specific cytokines [6]. Omega-3
polyunsaturated fatty acids (PUFAs) have a beneficial effect
by counteracting inflammation in cancer cells, which PUFAs
easily diffuse into via the plasma membrane, by stimulating the
production of anti-inflammatory metabolites [7]. PUFAs reduce
plasma lipid levels and lipoproteins by modulating hepatic
lipoprotein secretion [8] and likely by also mitigating
dyslipidemia effects. How obesity and diet might impact
melanoma onset and therapeutic efficacy has been discussed
[9]. Although obesity and abnormal lipid levels in the blood
represent established risk factors in other malignancies, they
do not seem to impact cutaneous melanoma [10]. In fact, they
are only slightly associated with an increased risk of cutaneous
melanoma in men [11], although insulin resistance and
dyslipidemia seem to promote the growth of uveal melanoma.
Interestingly, obesity has been associated with a better prognosis
and improved survival in patients undergoing treatment for
metastatic melanoma. A higher BMI appears to be a protective
factor in melanoma and this phenomenon has been named the
obesity paradox [12]. In several other cancers, including
colorectal cancer, being overweight and having a higher BMI
are known risk factors, rather than protective conditions [13].
Fat metabolism might be differently controlled in different
cancer cell types, thereby explaining why dyslipidemia may
play divergent roles in different cancers. Scavenger receptors
including macrophage receptor with collagenous structure
(MARCO) and CD36 recognize and internalize lipoproteins,
making them susceptible to degradation [14,15]. Furthermore,
fatty acid–binding proteins (FABPs) play an important role in
cancer progression and the intracellular transportation of
long-chain fatty acids [16]. These molecules exert a pivotal role
in regulating lipid metabolism.
The aim of this study was to investigate the expression of genes
related to lipid-handling to analyze the molecular basis of the
obesity paradox observed in melanoma.
Methods
Overview
The study was carried out in 3 steps: (1) a selection step was
carried out on a public database, IST (In Silico Transcriptomics)
Online, to identify genes of potential interest; (2) data collected
in the initial selection step were validated in a first-round
validation step with another database, GEO (Gene Expression
Omnibus); and (3) data were further validated in a subsequent
second-round validation step with a third database (Oncomine).
Table 1 shows the databases used throughout the process and
the types of patients investigated in each step.
First, in the selection step, the IST Online public database [17]
was used to obtain gene expression data. It returns plots
indicating the expression values of the given gene compared to
the expression value of a second given reference gene. This can
be carried out with several different cancer data sets and
corresponding healthy controls. The analysis was performed
with melanoma versus healthy skin and with colorectal cancer
versus healthy control biopsies. In turn, we indicated our genes
of interest (CD36, MARCO, FABP1, FABP2, FABP3, FABP4,
FABP6, or FABP7) as the first gene and used a known
housekeeping gene, beta-2 microglobulin (B2M), as the
reference gene; it should be noted that the expression values of
the first gene are independent from the reference gene and the
values do not change if a different reference gene is chosen. We
previously reported the methods used to study the expression
of other molecules to identify relevant melanoma markers [2].
We analyzed data from 1410 individuals, including 208 patients
with melanoma and 147 healthy controls, and 991 patients with
colorectal cancer and 64 healthy controls. The first-round
validation was carried out using the GEO public database [18].
The GDS1375 data set was used, which represents expression
data from 45 melanoma biopsies, 18 nevi biopsies, and 7 heathy
skin biopsies. The second-round validation was carried out on
the DNA-TCGA data set in the Oncomine database [19]. In this
case, 318 patients with melanoma were compared to 312 healthy
controls, and 435 patients with colorectal cancer were compared
to 445 healthy controls. The Human Protein Atlas public
database was also interrogated [20].
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Table 1. Schematic representation of the steps of this study.
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IST (In Silico Transcrip-
tomics) Online
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Within the scatterplots obtained from the IST Online database
analysis, the number of patients falling above or below the
chosen threshold were counted and analyzed according to the
Fisher exact test using GraphPad Prism 5 (GraphPad Software,
Inc).
Other statistical analyses were carried out on the expression
values obtained by querying the GEO database. Data was
analyzed with analysis of variance and analysis for the linear
trend from healthy to nevi to melanoma samples was carried
out, both with GraphPad Prism 5. The threshold for statistical
significance was set at P<.001.
Results
Overview
Gene expression of CD36, MARCO, and various FABP isoforms
in 355 patients (208 patients with melanoma versus 147 healthy
skin controls) was analyzed, according to the transcriptome
expression data reported in the IST Online database. Table 2
shows the results and indicates the statistical significance of
distribution above or below the given threshold, according to
the Fisher exact test, for both melanoma and colorectal cancer
data for all 8 genes investigated. The threshold value was chosen
as the value best discriminating the largest population within
the controls. The following threshold values were used: CD36:
1000; MARCO: 150; FABP1: 100 in melanoma and 1000 in
colorectal cancer; FABP2: 100; FABP3: 250; FABP4: 2000;
FABP6: 200; FABP7: 500. FABP5 does not appear in the IST
Online database.
Interestingly, the 4 genes that had a significant difference in
melanoma were not significantly different in patients with
colorectal cancer versus healthy controls, indicating that the
difference observed in melanoma appears to be cancer-specific.
Figure 1 indicates the expression values of the 5 genes that had
significant differences in melanoma versus healthy skin controls
(CD36, MARCO, FABP4, FABP6, and FABP7). The
significance of the distribution reported in Table 2 was computed
by counting the number of individuals falling below or above
the thresholds indicated by the dashed lines. The expression of
CD36, MARCO, FABP4, FABP6, and FABP7 in melanoma
samples and healthy skin biopsies is visualized, according to
data retrieved from the IST Online database.
These data indicate that melanoma samples show significantly
lower expression of genes involved in fatty acid uptake (CD36
and MARCO) and intracellular fatty acid binding (FABP4 and
FABP7) compared to healthy controls, and this phenomenon
was not observed in a colorectal cancer data set.
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Table 2. Expression in melanoma and colorectal cancer, according to the IST (In Silico Transcriptomics) Online database. Where P values are <.001,
there was a statistically significant difference between the respective cancer values versus control values, evaluated as distribution above or below the
given threshold, according to the Fisher exact test.
P valueRegulation in colorectal cancers
versus controls











Figure 1. Expression of CD36, MARCO, FABP4, FABP6, and FABP7 in melanoma and healthy skin samples from the IST (In Silico Transcriptomics)
Online data set. Each dot indicates one individual and dashed lines indicate the threshold used to calculate the statistical significance of the distribution
difference reported in Table 2. All reported genes show a significantly different distribution in melanoma versus controls according to the Fisher exact
test (P<.001).
First Validation Round
Data collected from the IST Online database were then validated
on a different database, GEO. Expression values in melanoma
were obtained from the GDS1375 data set, as detailed in the
Methods section. Figure 2 shows that the expression values of
CD36, MARCO, FABP4, and FABP7 are significantly decreased
in melanoma samples (n=45) compared to nevi (n=18) and
healthy skin (n=7) biopsies. A significant (P<.001) linear trend
from healthy controls to nevi to melanoma biopsies was
observed in CD36, MARCO, and FABP4. Therefore, the CD36,
MARCO, FABP4, and FABP7 data obtained from the IST Online
database were validated on the GEO database. FABP6, which
was increased in melanoma compared to control in the IST
Online database (Table 2), showed a weak, nonsignificant
increase in the GEO database (Figure 2).
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Figure 2. Expression of CD36, MARCO, FABP4, FABP6, and FABP7 in melanoma, nevi, and healthy skin biopsies from the GDS1375 data set on the
GEO (Gene Expression Omnibus) database. Changes observed in the GEO database were in the same direction as observed in the IST (In Silico
Transcriptomics) Online database for all genes except FABP6. Statistical significance was calculated by analysis of variance.
Second Validation Round
The 4 genes validated in GEO were further investigated in a
third public database, Oncomine. Table 3 shows the statistical
significance of the log2 copy number units change in the
DNA-TCGA data set expression data from patients with
melanoma and colorectal cancer compared to healthy controls,
as analyzed in the Oncomine database. This analysis validated
significant differences in CD36 and FABP4 expression in
melanoma versus controls, and no significant difference in
colorectal cancer.
Table 3. Gene expression in the DNA-TCGA data sets analyzed in the Oncomine databasea.
P values for the colorectal cancer
DNA-TCGA data set







aThe statistical significance of the differential log2 copy number in patients with melanoma or colorectal cancer versus controls is reported. The
significance threshold was set to P<.001.
A final investigation was then carried out using the Human
Protein Atlas public database. Although the potential roles of
the genes investigated in this study were not verified in
melanoma, their roles have been confirmed in other cancers.
Specifically, increased CD36 gene expression levels indicate
an unfavorable prognostic value in 354 patients with stomach
cancer (P<.001), and increased FABP7 gene expression levels
indicate an unfavorable prognostic value in 877 patients with
renal cancer (P<.001), yet indicate a favorable prognostic value
in 1075 patients with breast cancer.
Discussion
In this study we investigated the expression of different genes
involved in lipid metabolism and found a significant difference
in melanoma versus controls. This may explain part of the
mechanism behind the obesity paradox observed in patients
undergoing treatment for metastatic melanoma. The mechanisms
underlying the association between dyslipidemia and melanoma
remain controversial; this is due to the different metabolic
controls within bulk melanoma cells and cancer stem cells or
metastasis-initiating cells [21,22]. Metastasis-initiating cells
display high CD36 levels, which may indicate a crucial
contribution of dietary lipids in the promotion of metastasis
[23]. Furthermore, as we previously demonstrated, melanoma
cancer stem cells show higher intracellular neutral lipids, higher
lipogenesis activation, and lower autophagic flux [24]. This
evidence indicates a complex molecular apparatus that allows
melanoma cells to finely regulate fatty acid storage and
mobilization depending on the metabolic environment and their
differentiation level.
FABP4 and FABP2 have recently been reported to have a
significant association with cancer progression in patients with
colorectal cancer [16] and several studies demonstrate that
obesity and high fat intake are risk factors in colorectal cancer
JMIR Cancer 2020 | vol. 6 | iss. 1 | e16974 | p. 5http://cancer.jmir.org/2020/1/e16974/
(page number not for citation purposes)
Giampietri et alJMIR CANCER
XSL•FO
RenderX
[13,25-28]. On the other hand, several studies highlight the
obesity paradox in melanoma, reporting significantly lower
mortality in overweight patients undergoing treatment for
melanoma [29], although a recent publication indicated that
some caution is warranted [30]. Patients with melanoma or
colorectal cancer appear to respond in opposite ways to high
dietary fat intake or fat metabolism and may therefore be useful
models to investigate how lipid-related gene expression may
differentially regulate cancer initiation. For this reason, this
study investigated lipid-related gene expression in patients with
melanoma or colorectal cancer. Many genes have been identified
as lipid modulators, although this field still remains poorly
investigated. Genes controlling dyslipidemia in mice were
recently reported [31], as well as other molecules that interfere
with lipid storage [32,33], while a complete list of lipid-related
genes in humans is currently lacking. In this work we
investigated the expression of 8 genes (FABPs and other
lipid-related genes) in melanoma and colorectal cancer biopsies,
hypothesizing that differences in melanoma and colorectal
cancer gene expression may partly explain the different role
dietary fat plays in melanoma (ie, protective) and colorectal
cancer (ie, detrimental). A significant reduction of the genes
for scavenger receptors CD36 and MARCO (which are able to
bind lipoproteins) and FABP4 and FABP7 translocases (which
are able to bind and cell-internalize fatty acids) was found in
melanoma biopsies compared to healthy controls, according to
2 independent databases, IST Online and GEO. We hypothesize
that this reduced expression may lead to a reduced uptake of
lipids and reduced cellular internalization. CD36 and FABP4
were also validated in a third database, Oncomine, using the
DNA-TCGA data set. These genes showed no difference in
control expression data compared to data from patients with
colorectal cancer, for whom high fat dietary intake represents
a negative prognostic factor. Therefore, we believe that the
reduced gene expression observed in melanoma (571 patients
and 484 controls, in 3 independent databases) might contribute
to counteracting the detrimental effects of high fat intake.
More extensive analyses are ongoing in other cancers and on a
larger list of relevant lipid-related genes; nevertheless, the results
from this study may reveal some of the molecular mechanisms
responsible for the obesity paradox observed in melanoma.
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